Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 336,477 | 130,893 | 134,930 | 116,808 | 108,636 |
| Marketable Securities | 217,789 | 230,346 | 278,756 | 337,366 | 360,070 |
| Receivables | 70,129 | 58,890 | 68,145 | 41,139 | 35,399 |
| Inventories | 33,164 | 34,948 | 32,754 | 25,000 | 17,696 |
| TOTAL | $675,039 | $471,177 | $528,081 | $529,830 | $531,676 |
| Non-Current Assets | |||||
| PPE Net | 212 | 177 | 181 | 128 | N/A |
| Investments And Advances | 27,217 | 0 | 0 | 20,146 | 62,627 |
| Other Non-Current Assets | 1,184 | 1,314 | 1,444 | 1,688 | 1,846 |
| TOTAL | $28,613 | $1,491 | $1,625 | $21,962 | $64,473 |
| Total Assets | $703,652 | $472,668 | $529,706 | $551,792 | $596,149 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 22,925 | 19,435 |
| Accounts payable and accrued liabilities | 4,874 | 10,843 | 16,580 | 13,826 | 22,136 |
| Accrued Expenses | 94,297 | 74,843 | 103,064 | 77,105 | 71,066 |
| TOTAL | $99,677 | $86,174 | $120,116 | $114,187 | $112,987 |
| Non-Current Liabilities | |||||
| Long Term Debt | 244,090 | 343,965 | N/A | 320,985 | 324,413 |
| Other Non-Current Liabilities | 760 | 907 | 1,051 | 1,190 | 1,325 |
| TOTAL | $588,876 | $344,872 | $344,960 | $322,175 | $325,738 |
| Total Liabilities | $688,553 | $431,046 | $465,076 | $436,362 | $438,725 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 89,297 | 88,610 | 88,201 | 86,915 | 86,142 |
| Common Shares | 9 | 9 | 9 | 9 | 9 |
| Retained earnings | -1,598,616 | -1,549,253 | -1,506,580 | -1,438,566 | -1,377,851 |
| Other shareholders' equity | -140 | 11 | 452 | 525 | 285 |
| TOTAL | $15,099 | $41,622 | $64,630 | $115,430 | $157,424 |
| Total Liabilities And Equity | $703,652 | $472,668 | $529,706 | $551,792 | $596,149 |